company
ENDO USA, Inc.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-05-20ENDO USA, Inc. — Class II recall: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx o…
Frequently asked questions
- How many FDA warning letters has ENDO USA, Inc. received?
- Argus HQ has not recorded an FDA warning letter for ENDO USA, Inc. in our current dataset.
- What FDA recalls has ENDO USA, Inc. issued?
- Argus HQ has recorded 1 FDA recall tied to ENDO USA, Inc..
- Is ENDO USA, Inc. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for ENDO USA, Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

